Get started today
Inflammatory Bowel Disease: Therapeutic Approach with Phytocannabinoids
Presented by Dr Facundo Alvarez, MD
About this module:
Inflammatory Bowel Disease (IBD) is an inflammatory condition of the gastrointestinal tract that is subdivided into ulcerative colitis and Crohn’s Disease. IBD results in significant suffering for those afflicted and there are a range of risk factors. In this presentation, one of Argentina’s foremost experts in medicinal cannabis, Dr Facundo Alvarez MD comprehensively explores IBD, the role of the endocannabinoid system (ECS) in modulation of the gastrointestinal tract and the scientific evidence investigating outcomes of manipulation of various ECS targets including cannabinoid receptor agonists and agents inhibiting FAAH. He also presents scientific evidence investigating medicinal cannabis, cannabidiol (CBD), tetrahydrocannabinol (THC) and palmitoylethanolamide (PEA) in the treatment of IBD.
This presentation is a deep dive into the research evidence, covering animal and human research findings, and is suitable for healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Learning Outcomes